A second major office lease at Skanska’s 421,320-square-foot, 17-story office high-rise slated to deliver early next year at 121 Seaport Blvd. in Boston’s Seaport District has brought the elliptical-shaped tower to full occupancy.

Alexion Pharmaceuticals finalized a deal that will see the global biopharmaceutical relocate its corporate offices from New Haven, CT to 150,000 square feet across the third through eighth floors of 121 Seaport beginning…

Article From: "Key Realty Commercial Real Estate News"   Read full article